Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

OSLO, Norway, April 29, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces four abstract presentations at the AUA 2025, highlighting the benefits of Blue Light ...

OSLO, Norway, Feb. 17, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S. bladder ...

Findings from an interim analysis of data show that the addition of blue light cystoscopy to conventional white light significantly improved clinical outcomes in a group of patients with ...

Add Yahoo as a preferred source to see more of our stories on Google. Research shows a urine test looking for genetic markers of bladder cancer can more than halve the number of cystoscopies needed to ...

Bladder cancer is one of the most common cancer types in the U.S., according to the National Cancer Institute. It's also one of the most likely types of cancer to recur. Experts are developing ways to ...

A urine test developed at Stanford Medicine identified 95 of 100 bladder cancers in a proof-of-concept study published in ...

A new urine test has shown promise in detecting bladder cancer, including early-stage cases, by analysing RNA molecules. Here ...

When using a diagnostic tool, it is common see to more false-positives as the number of true-positives increases ( Table 1). The accuracy of fluorescence cystoscopy is also affected by previous ...

A new urine-based testing method has shown promising results in detecting bladder cancer, including early-stage cases. The research suggests that analysing tiny RNA molecules present in urine could ...

A bladder cancer diagnosis can be overwhelming. As a caregiver, you can play an important role in navigating a loved one’s ...

Data from patients treated in the late 1990s is now emerging, making it possible to assess the effect of improved detection and subsequent changes in patient management on recurrence rates ( Table 2).